Literature DB >> 21678108

The behavior of matrix metalloproteinase-9 in lymphocytic colitis, collagenous colitis and ulcerative colitis.

Gábor Lakatos1, Ferenc Sipos, Pál Miheller, István Hritz, Mária Zsófia Varga, Márk Juhász, Béla Molnár, Zsolt Tulassay, László Herszényi.   

Abstract

Matrix metalloproteinases play an important role in extracellular matrix remodelling. It has been proposed that matrix metalloproteinase-9 (MMP-9) is involved in epithelial damage in ulcerative colitis (UC). However, to our knowledge, no data are available in terms of MMP-9 expression in microscopic colitis. Determination of mucosal protein expression levels of MMP-9 in lymphocytic colitis (LC), collagenous colitis (CC) and UC. MMP-9 immunohistochemical expressions were analyzed in paraffin-embedded tissue samples by immunohistochemistry including patients with LC, CC, UC, active diverticulitis, inactive diverticular disease and healthy control subjects. UC was also subgrouped according to the severity of inflammation. Immunostaining was determined semiquantitatively. Independent colonic biopsies from healthy and severe UC cases were used for gene expression analyses. For further comparison MMP-9 serum antigen levels were also determined in patients with UC and control patients without macroscopic or microscopic changes during colonoscopy. MMP-9 mucosal expression was significantly higher in UC (26.7 ± 19.5%) compared to LC (6.6 ± 9.3%), CC (6.4 ± 7.6%), active diverticulitis (5.33 ± 2.4%), inactive diverticular disease (5.0 ± 2.2%) and controls (6.3 ± 2.6%) (P < 0.001). The immunohistochemical expression of MMP-9 in LC and CC was similar as compared to controls. MMP-9 expression was significantly higher in each inflammatory group of UC compared to controls (mild: 11.0 ± 2.8%, moderate: 23.9 ± 3.7%, severe UC: 52.6 ± 3.9% and 6.3 ± 2.6%, respectively, P < 0.005). The gene expression microarray data and RT-PCR results demonstrated a significantly higher expression of MMP-9 in severely active UC compared to healthy controls (P < 0.001). Significantly higher MMP-9 serum antigen concentrations were observed in UC patients compared with the control group (P < 0.05). MMP-9 seems to play no role in the inflammatory process of LC and CC. In contrast, the mucosal up-regulation of MMP-9 correlated with the severity of inflammation in UC. The increased MMP-9 expression could contribute to the severity of mucosal damage in active UC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21678108     DOI: 10.1007/s12253-011-9420-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  37 in total

1.  Historical origins of current IBD concepts.

Authors:  J B Kirsner
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 2.  Collagenous colitis evolving into ulcerative colitis: a case report and review of the literature.

Authors:  Bashar Aqel; Michele Bishop; Murli Krishna; John Cangemi
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

3.  Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel diseases: ulcerative colitis shows specific p53- and EGFR expression alterations.

Authors:  Ferenc Sipos; Béla Molnár; Tamás Zágoni; Lajos Berczi; Zsolt Tulassay
Journal:  Dis Colon Rectum       Date:  2005-04       Impact factor: 4.585

4.  Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases.

Authors:  Q Gao; M J W Meijer; F J G M Kubben; C F M Sier; L Kruidenier; W van Duijn; M van den Berg; R A van Hogezand; C B H W Lamers; H W Verspaget
Journal:  Dig Liver Dis       Date:  2005-08       Impact factor: 4.088

5.  Matrix metalloproteinase levels are elevated in inflammatory bowel disease.

Authors:  M D Baugh; M J Perry; A P Hollander; D R Davies; S S Cross; A J Lobo; C J Taylor; G S Evans
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

6.  Cysteine and serine proteases in gastric cancer.

Authors:  M Plebani; L Herszènyi; R Cardin; G Roveroni; P Carraro; M D Paoli; M Rugge; W F Grigioni; D Nitti; R Naccarato
Journal:  Cancer       Date:  1995-08-01       Impact factor: 6.860

7.  Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcer.

Authors:  L Herszènyi; M Plebani; P Carraro; M De Paoli; R Cardin; F Di Mario; S Kusstatscher; R Naccarato; F Farinati
Journal:  Am J Gastroenterol       Date:  1997-05       Impact factor: 10.864

8.  Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine.

Authors:  C J Bailey; R M Hembry; A Alexander; M H Irving; M E Grant; C A Shuttleworth
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

Review 9.  Microscopic colitis: a missed diagnosis?

Authors:  Ole Haagen Nielsen; Ben Vainer; Ove B Schaffalitzky de Muckadell
Journal:  Lancet       Date:  2004 Dec 4-10       Impact factor: 79.321

10.  Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.

Authors:  László Herszényi; Ferenc Sipos; Orsolya Galamb; Norbert Solymosi; István Hritz; Pál Miheller; Lajos Berczi; Béla Molnár; Zsolt Tulassay
Journal:  Pathol Oncol Res       Date:  2008-03-18       Impact factor: 3.201

View more
  22 in total

1.  Surgical diverticulitis is not associated with defects in the expression of wound healing genes.

Authors:  Tara M Connelly; Arthur S Berg; Leonard R Harris; Rafel Tappouni; Dave Brinton; Sue Deiling; Walter A Koltun
Journal:  Int J Colorectal Dis       Date:  2015-05-24       Impact factor: 2.571

2.  Expression Profiling of Inflammatory and Immunological Genes in Collagenous Colitis.

Authors:  Qingqing Liu; Noam Harpaz
Journal:  J Crohns Colitis       Date:  2019-05-27       Impact factor: 9.071

3.  Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.

Authors:  Prashant Nighot; Rana Al-Sadi; Manmeet Rawat; Shuhong Guo; D Martin Watterson; Thomas Ma
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-29       Impact factor: 4.052

4.  Butein effects in colitis and interleukin-6/signal transducer and activator of transcription 3 expression.

Authors:  Sehe Dong Lee; Jung Wan Choe; Beom Jae Lee; Myoung Hee Kang; Moon Kyung Joo; Ji Hoon Kim; Jong Eun Yeon; Jong-Jae Park; Jae Seon Kim; Young-Tae Bak
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

5.  Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9.

Authors:  Todd C Appleby; Andrew E Greenstein; Magdeleine Hung; Albert Liclican; Maile Velasquez; Armando G Villaseñor; Ruth Wang; Melanie H Wong; Xiaohong Liu; Giuseppe A Papalia; Brian E Schultz; Roman Sakowicz; Victoria Smith; Hyock Joo Kwon
Journal:  J Biol Chem       Date:  2017-02-24       Impact factor: 5.157

6.  Protective role of metalloproteinase inhibitor (AE-941) on ulcerative colitis in rats.

Authors:  Jing-Wei Mao; Xiao-Mei He; Hai-Ying Tang; Ying-De Wang
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 7.  Microscopic colitis: Common cause of unexplained nonbloody diarrhea.

Authors:  Sachin B Ingle; Baban D Adgaonkar; Chitra R Hinge Ingle
Journal:  World J Gastrointest Pathophysiol       Date:  2014-02-15

Review 8.  Impact of proteolytic enzymes in colorectal cancer development and progression.

Authors:  László Herszényi; Loránd Barabás; István Hritz; Gábor István; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

9.  Multi-factor mediated functional modules identify novel classification of ulcerative colitis and functional gene panel.

Authors:  Lijie Lai; Hanyang Li; Qi Feng; Jun Shen; Zhihua Ran
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

Review 10.  The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.

Authors:  László Herszényi; István Hritz; Gábor Lakatos; Mária Zsófia Varga; Zsolt Tulassay
Journal:  Int J Mol Sci       Date:  2012-10-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.